Evercore ISI Sticks to Their Buy Rating for Omada Health, Inc. (OMDA)

Tip Ranks
2025.11.18 10:37
portai
I'm PortAI, I can summarize articles.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Omada Health, Inc. with a price target of $28.00. The shares closed at $19.46. Anderson has an average return of -2.4% and a 47.80% success rate. Morgan Stanley also issued a Buy rating, while TR reiterated a Hold rating on Omada Health, Inc.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Omada Health, Inc. yesterday and set a price target of $28.00. The company’s shares closed yesterday at $19.46.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Anderson CFA is an analyst with an average return of -2.4% and a 47.80% success rate. Anderson CFA covers the Healthcare sector, focusing on stocks such as Henry Schein, Align Tech, and Envista Holdings.

In addition to Evercore ISI, Omada Health, Inc. also received a Buy from Morgan Stanley’s Craig Hettenbach in a report issued yesterday. However, on November 8, TR | OpenAI – 4o reiterated a Hold rating on Omada Health, Inc. (NASDAQ: OMDA).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer